menu ☰
menu ˟

AF thromboembolic prophylaxis should focus on drug efficacy, not pharmacologic class

25 Mar 2015
In patients with atrial fibrillation, researchers found no significant class effect for direct thrombin inhibitors or factor Xa inhibitors, according to meta-analysis results. In addition, they saw no pronounced benefit for a particular dosing regime...

Click here to view the full article which appeared in

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.